Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5318)
All Articles published online
|
Publishing Process of This Article
|
Dec 18, 2023 (publication date) through Jun 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Acharya S, Lama S, Kanigicherla DA. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection. World J Transplant 2023; 13(6): 299-308 [PMID: 38174145 DOI: 10.5500/wjt.v13.i6.299] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v13/i6/299.htm |
| Number | Citing Articles |
| 1 |
Sarah A. Albilal, Mohammed A. Gafar, Wesam S. Abdel-Razaq, Sarah Almugbil, Mohammed Alotaibi, Aiman A. Obaidat, Mohammad S. Shawaqfeh, Abdulkareem M. Albekairy. Evaluating ATG Induction Therapy Outcomes After Commercial Kidney Transplantation: Insights from a Tertiary Hospital Experience. Journal of Clinical Medicine 2025; 14(6): 1896 doi: 10.3390/jcm14061896
|
| 2 |
Anca Butuca, Laurentiu Stoicescu, Mirela Livia Popa, Carmen Maximiliana Dobrea, Adriana Muntean, Claudiu Morgovan, Corina Pienar, Felicia Gabriela Gligor, Steliana Ghibu, Ioana Rada Popa Ilie, Adina Frum. Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study. Journal of Clinical Medicine 2025; 14(10): 3409 doi: 10.3390/jcm14103409
|
| 3 |
Keila C. Ostos-Mendoza, Valeria Saraiba-Rabanales, Paola Gutierrez-Gallegos, Emily Wang, Efstratios Koutroumpakis, Salil Kumar, Shaden Khalaf, Hyeon-Ju Ali, Anita Deswal, Nicolas L. Palaskas. Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge. The Journal of Cardiovascular Aging 2025; 5(1) doi: 10.20517/jca.2024.13
|
| 4 |
Lukas K. van Vugt, Erzsi Tegzess, Marieke van der Zwan, Marian C. Clahsen‐van Groningen, Brenda C. M. de Winter, Priya Vart, Marlies E. J. Reinders, Jan Stephan F. Sanders, Stefan P. Berger, Dennis A. Hesselink. Multicenter, Real‐World Clinical Evaluation of Alemtuzumab and Anti‐Thymocyte Globulin for Severe Acute T Cell‐Mediated Kidney Transplant Rejection. Clinical Transplantation 2024; 38(12) doi: 10.1111/ctr.70046
|
| 5 |
Rahul Mittal, Keelin McKenna, Joana R. N. Lemos, Shreya Juneja, Mannat Mittal, Khemraj Hirani, Shafiya Imtiaz Rafiqi. Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review. PLOS One 2025; 20(5): e0323642 doi: 10.1371/journal.pone.0323642
|
| 6 |
Andreea Grosu-Bularda, Florin-Vlad Hodea, Dragos Zamfirescu, Alexandru Stoian, Răzvan Nicolae Teodoreanu, Ioan Lascăr, Cristian Sorin Hariga. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?. Journal of Personalized Medicine 2024; 14(3): 322 doi: 10.3390/jpm14030322
|